MedTrace Logo

Medication Treatment of ADHD in Pediatric Epilepsy

NCT07594652 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-05-19

No results posted yet for this study

Summary

This is an observational study assessing the usage of stimulant medication for ADHD in the context of pediatric epilepsy.

Conditions

  • ADHD - Attention Deficit Disorder With Hyperactivity

Interventions

DRUG

methylphenidate hydrochloride (Jornay PM)

all participants will receive active treatment

Sponsors & Collaborators

  • Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

    lead OTHER

Principal Investigators

  • Jay Salpekar, MD · Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2030-12-31
Completion
2030-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07594652 on ClinicalTrials.gov